Search results
Allie Goss, BA, MA. Research Assistant. Salome Mouliere. Undergraduate Research Student. Alumni. Priya Pancholi, BPharm, MS, New York University. Dorota Sadowicz, MS, Bio-Rad, Inc. Bart Lutterbach, PhD, Staff Scientist, Center for Protein Degradation, Dana-Farber Cancer Institute. Sascha DeVine, BS, Principal Research Associate, FogPharma.
At Dana-Farber Brigham Cancer Center's Breast Oncology Program, our multi-disciplinary team works closely with patients, providing the resources and close cooperation of many specialists with deep expertise in diagnosing and treating breast cancer.
Benjamin Ebert, MD, PhD, chair of Medical Oncology at Dana-Farber Cancer Institute, is professor of Medicine at Harvard Medical School, an institute member of the Broad Institute, and leader of the Leukemia Program for the Dana-Farber/Harvard Cancer Center. His research focuses on the genetics, biology, and therapy of myeloid malignancies.
877-442-3324. REQUEST AN APPOINTMENT. Dana-Farber Cancer Institute's Division of Cancer Genetics and Prevention offers a unique team approach to genetic testing and cancer risk management. We provide an initial cancer risk evaluation with an experienced genetic counselor and physician to discuss your personal and family history.
Jan 31, 2023 · EXCLUSIVE: Former Made Up Stories and Netflix executive Allie Goss has been appointed President of Brillstein Creative Partners, the production arm of Brillstein Entertainment Partners. Goss,...
Dana-Farber is the founding member of the Dana-Farber/Harvard Cancer Center, Harvard's Comprehensive Cancer Center designated by the National Cancer Institute, and one of the 15 clinical affiliates and research institutes of Harvard Medical School. As of 2023, Dana-Farber is ranked the #4 cancer hospital in the world.
Dana-Farber Cancer Institute in Boston, MA, is a world leader in adult and pediatric cancer treatment and research. Our oncologists and cancer researchers practice and develop some of the most advanced cancer treatments in the world.
